SCHEDULE 13G

Company

LIGAND PHARMACEUTICALS INC

Filed

April 14, 2004

Accession Number

0000950133-04-001375

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →